Richard D. Patten

5.2k total citations · 1 hit paper
53 papers, 3.8k citations indexed

About

Richard D. Patten is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Richard D. Patten has authored 53 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Richard D. Patten's work include Heart Failure Treatment and Management (13 papers), Cardiac electrophysiology and arrhythmias (11 papers) and Cardiovascular Function and Risk Factors (10 papers). Richard D. Patten is often cited by papers focused on Heart Failure Treatment and Management (13 papers), Cardiac electrophysiology and arrhythmias (11 papers) and Cardiovascular Function and Risk Factors (10 papers). Richard D. Patten collaborates with scholars based in United States, Japan and Italy. Richard D. Patten's co-authors include Thomas Force, Mark Aronovitz, Marvin A. Konstam, Richard H. Karas, Michael E. Mendelsohn, Robert Salomon, Brian Walters, Risto Kerkelä, Sergei Shevtsov and Anthony Rosenzweig and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Richard D. Patten

51 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

2006 858 citations Risto Kerkelä, Luanda Grazette et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard D. Patten United States	30	2.0k	1.2k	517	411	374	53	3.8k
Friedrich Thaiss Germany	35	813 0.4×	1.2k 1.0×	577 1.1×	558 1.4×	160 0.4×	116	4.9k
René J.P. Musters Netherlands	37	1.5k 0.7×	1.3k 1.1×	509 1.0×	261 0.6×	168 0.4×	94	4.6k
Christos Chatziantoniou France	41	1.3k 0.6×	1.4k 1.1×	510 1.0×	201 0.5×	173 0.5×	133	4.2k
Risto Kerkelä Finland	31	2.2k 1.1×	2.0k 1.7×	536 1.0×	1.1k 2.6×	569 1.5×	86	4.6k
Abdelkarim Sabri United States	36	1.4k 0.7×	1.9k 1.6×	555 1.1×	278 0.7×	297 0.8×	59	3.5k
Gregor Theilmeier Germany	34	1.1k 0.5×	1.2k 1.0×	1.0k 2.0×	254 0.6×	453 1.2×	83	4.0k
Ratnadeep Basu Canada	35	2.2k 1.1×	1.2k 1.0×	713 1.4×	289 0.7×	196 0.5×	52	4.1k
Daniel T. Eitzman United States	38	1.5k 0.8×	1.0k 0.8×	789 1.5×	192 0.5×	1.1k 2.9×	100	5.2k
Mónica Rupérez Spain	27	1.7k 0.8×	1.4k 1.2×	408 0.8×	289 0.7×	85 0.2×	29	4.0k
Nerea Varo Spain	37	1.9k 0.9×	896 0.7×	675 1.3×	423 1.0×	250 0.7×	85	4.3k

Countries citing papers authored by Richard D. Patten

Since Specialization

Citations

This map shows the geographic impact of Richard D. Patten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Patten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Patten more than expected).

Fields of papers citing papers by Richard D. Patten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Patten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Patten. The network helps show where Richard D. Patten may publish in the future.

Co-authorship network of co-authors of Richard D. Patten

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Patten. A scholar is included among the top collaborators of Richard D. Patten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Patten. Richard D. Patten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patten, Richard D., et al.. (2022). END STAGE CARDIAC HEMOCHROMATOSIS IN A TRANSFUSION-DEPENDENT PATIENT WITH DIAMOND BLACKFAN ANEMIA. Journal of the American College of Cardiology. 79(9). 2270–2270.

Venesy, David, et al.. (2019). Outcomes of Impella CP insertion during cardiac arrest: A single center experience. Resuscitation. 147. 53–56. 8 indexed citations

Ganatra, Sarju, Anju Nohria, Sachin Shah, et al.. (2019). Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series. Cardio-Oncology. 5(1). 1–1. 57 indexed citations

Ganatra, Sarju, Ajay Sharma, Sachin Shah, et al.. (2018). Ibrutinib-Associated Atrial Fibrillation. JACC. Clinical electrophysiology. 4(12). 1491–1500. 137 indexed citations

O’Connor, Christopher M., Alan B. Miller, John E. Blair, et al.. (2010). Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program. American Heart Journal. 159(5). 841–849.e1. 193 indexed citations

Patten, Richard D., et al.. (2009). The Effect of Ventricular Assist Devices on Post-Transplant Mortality. Journal of the American College of Cardiology. 53(3). 264–271. 75 indexed citations

Patten, Richard D., Mark Aronovitz, Alawi Alsheikh‐Ali, et al.. (2008). 17 Beta-Estradiol Differentially Affects Left Ventricular and Cardiomyocyte Hypertrophy Following Myocardial Infarction and Pressure Overload. Journal of Cardiac Failure. 14(3). 245–253. 66 indexed citations

Park, Hojin, S Georgescu, Chuang Du, et al.. (2008). Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP. Journal of Clinical Investigation. 118(1). 259–271. 140 indexed citations

Hajjar, Roger J., Krisztina M. Zsebo, Lawrence I. Deckelbaum, et al.. (2008). Design of a Phase 1/2 Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Heart Failure. Journal of Cardiac Failure. 14(5). 355–367. 152 indexed citations

10.

Brieke, Andreas, Rajan Krishnamani, Wenjun Li, et al.. (2008). Influence of Donor Cocaine Use on Outcome After Cardiac Transplantation: Analysis of the United Network for Organ Sharing Thoracic Registry. The Journal of Heart and Lung Transplantation. 27(12). 1350–1352. 20 indexed citations

11.

Huggins, Gordon S., John J. Lepore, Sarah R. Greytak, et al.. (2007). The CREB leucine zipper regulates CREB phosphorylation, cardiomyopathy, and lethality in a transgenic model of heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 293(3). H1877–H1882. 19 indexed citations

12.

Goruppi, Sandro, Richard D. Patten, Thomas Force, & John Kyriakis. (2006). Helix-Loop-Helix Protein p8, a Transcriptional Regulator Required for Cardiomyocyte Hypertrophy and Cardiac Fibroblast Matrix Metalloprotease Induction. Molecular and Cellular Biology. 27(3). 993–1006. 44 indexed citations

13.

Kerkelä, Risto, Luanda Grazette, Rinat Yacobi, et al.. (2006). Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nature Medicine. 12(8). 908–916. 858 indexed citations breakdown →

14.

Patten, Richard D. & Richard H. Karas. (2006). Estrogen Replacement and Cardiomyocyte Protection. Trends in Cardiovascular Medicine. 16(3). 69–75. 48 indexed citations

15.

Patten, Richard D., David DeNofrio, Rahul Kakkar, et al.. (2005). Ventricular Assist Device Therapy Normalizes Inducible Nitric Oxide Synthase Expression and Reduces Cardiomyocyte Apoptosis in the Failing Human Heart. Journal of the American College of Cardiology. 45(9). 1419–1424. 29 indexed citations

16.

Bridgman, Paul, Mark Aronovitz, Rahul Kakkar, et al.. (2005). Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor. American Journal of Physiology-Heart and Circulatory Physiology. 289(2). H586–H592. 32 indexed citations

17.

Patten, Richard D., et al.. (2005). Current treatment options for CHF management: Focus on the renin-angiotensin-aldosterone system. Current Treatment Options in Cardiovascular Medicine. 7(1). 3–13. 1 indexed citations

18.

Michael, Ashour, Syed Haq, Xin Chen, et al.. (2004). Glycogen Synthase Kinase-3β Regulates Growth, Calcium Homeostasis, and Diastolic Function in the Heart. Journal of Biological Chemistry. 279(20). 21383–21393. 110 indexed citations

19.

Eickels, Martin van, Richard D. Patten, Mark Aronovitz, et al.. (2003). 17-Beta-Estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. Journal of the American College of Cardiology. 41(11). 2084–2092. 68 indexed citations

20.

Taylor, Kenneth W., Richard D. Patten, John J. Smith, et al.. (1998). Divergent Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin II-Receptor Antagonism on Myocardial Cellular Proliferation and Collagen Deposition After Myocardial Infarction in Rats. Journal of Cardiovascular Pharmacology. 31(5). 654–660. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact